Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,130 | -93,783 | -43,843 | -126,874 | -89,362 |
| Depreciation Amortization | -1,568 | -1,488 | -702 | -2,562 | -1,294 |
| Accounts receivable | 599 | 653 | 664 | -4,859 | -7,359 |
| Other Working Capital | -10,850 | 2,654 | -2,586 | 4,933 | -10,598 |
| Other Operating Activity | 14,830 | 10,115 | 4,443 | 32,596 | 25,466 |
| Operating Cash Flow | $-124,119 | $-81,849 | $-42,024 | $-96,766 | $-83,147 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 34,113 | 2,628 | -25,919 | -20,318 | -81,054 |
| PPE Investments | -272 | -185 | -44 | -295 | -180 |
| Investing Cash Flow | $33,841 | $2,443 | $-25,963 | $-20,613 | $-81,234 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 24,488 | 24,488 |
| Common Stock Issued | 7,973 | 3 | 34 | 170,131 | 169,810 |
| Other Financing Activity | 629 | 327 | 0 | 0 | 250 |
| Financing Cash Flow | $8,602 | $330 | $34 | $194,619 | $194,548 |
| Beginning Cash Position | 173,062 | 173,062 | 173,062 | 95,823 | 95,822 |
| End Cash Position | 91,386 | 93,986 | 105,109 | 173,063 | 125,989 |
| Net Cash Flow | $-81,676 | $-79,076 | $-67,953 | $77,240 | $30,167 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,119 | -81,849 | -42,024 | -96,766 | -83,147 |
| Capital Expenditure | -272 | -185 | -44 | -295 | -180 |
| Free Cash Flow | -124,391 | -82,034 | -42,068 | -97,061 | -83,327 |